Secondary Logo

Journal Logo

March 2009 - Volume 29 - Issue 3
pp: 289-426


EFFICACY OF 1.25 MG VERSUS 2.5 MG INTRAVITREAL BEVACIZUMAB FOR DIABETIC MACULAR EDEMA: Six-Month Results of a Randomized Controlled Trial

LAM, DENNIS S. C.; LAI, TIMOTHY Y. Y.; LEE, VINCENT Y. W.; More

Retina. 29(3):292-299, March 2009.

ASSOCIATION OF THE EXTENT OF DIABETIC MACULAR EDEMA AS ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY WITH VISUAL ACUITY AND RETINAL OUTCOME VARIABLES

BROWNING, DAVID J.; APTE, RAJENDRA S.; BRESSLER, SUSAN B.; More

Retina. 29(3):300-305, March 2009.

BEVACIZUMAB IS NOT TOXIC TO RETINAL GANGLION CELLS AFTER REPEATED INTRAVITREAL INJECTION

CHENG, CHENG-KUO; PENG, PAI-HUEI; TIEN, LU-TAI; More

Retina. 29(3):306-312, March 2009.

SAFETY OF REPEAT INTRAVITREAL INJECTIONS OF BEVACIZUMAB VERSUS RANIBIZUMAB: Our Experience After 2,000 Injections

LADAS, IOANNIS D.; KARAGIANNIS, DIMITRIOS A.; ROUVAS, ALEXANDROS A.; More

Retina. 29(3):313-318, March 2009.

INTRAVITREAL INJECTION OF 2.5 mg VERSUS 1.25 mg BEVACIZUMAB (AVASTIN) FOR TREATMENT OF CNV ASSOCIATED WITH AMD

MODARRES, MEHDI; NASERIPOUR, MASOOD; FALAVARJANI, KHALIL GHASEMI; More

Retina. 29(3):319-324, March 2009.

FIRST VERSUS SECOND EYE INTRAVITREAL RANIBIZUMAB THERAPY FOR WET AMD

ELDALY, MOHAMED A.; STYLES, CAROLINE

Retina. 29(3):325-328, March 2009.

RETINAL FUNCTIONAL CHANGES MEASURED BY MICROPERIMETRY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS TREATED WITH RANIBIZUMAB

PARRAVANO, MARIACRISTINA; ODDONE, FRANCESCO; TEDESCHI, MASSIMILIANO; More

Retina. 29(3):329-334, March 2009.

CLASSIFICATION OF FULL-THICKNESS TRAUMATIC MACULAR HOLES BY OPTICAL COHERENCE TOMOGRAPHY

HUANG, JINGJING; LIU, XING; WU, ZIQIANG; More

Retina. 29(3):340-348, March 2009.

TRAUMATIC MACULAR HOLES SECONDARY TO COMBAT OCULAR TRAUMA

WEICHEL, ERIC D.; COLYER, MARCUS H.

Retina. 29(3):349-354, March 2009.

MACULAR HOLE IN PROLIFERATIVE DIABETIC RETINOPATHY WITH FIBROVASCULAR PROLIFERATION

YEH, PO-TING; CHENG, CHENG-KUO; CHEN, MUH-SHY; More

Retina. 29(3):355-361, March 2009.

INTRAVITREAL VORICONAZOLE: In Vitro Safety-Profile for Fungal Endophthalmitis

KERNT, MARCUS; NEUBAUER, ALJOSCHA S.; DE KASPAR, HERMINIA MINO; More

Retina. 29(3):362-370, March 2009.

INVOLVEMENT OF ILLUMINATION IN INDOCYANINE GREEN TOXICITY AFTER ITS WASHOUT IN THE EX VIVO RAT RETINA

TOKUDA, KAZUHIRO; ZORUMSKI, CHARLES F.; IZUMI, YUKITOSHI

Retina. 29(3):371-379, March 2009.

ULTRASTRUCTURAL CHANGES OF THE INTERNAL LIMITING MEMBRANE REMOVED DURING INDOCYANINE GREEN ASSISTED PEELING VERSUS CONVENTIONAL SURGERY FOR IDIOPATHIC MACULAR EPIRETINAL MEMBRANE

KONSTANTINIDIS, LAZAROS; UFFER, SYLVIE; BOVEY, ETIENNE H.

Retina. 29(3):380-386, March 2009.

A RANDOMIZED COMPARISON OF PARECOXIB/VALDECOXIB AND PLACEBO FOR THE PREVENTION OF CYSTOID MACULAR EDEMA AFTER SCLERAL BUCKLING SURGERY

BENSON, SARAH E.; RATCLIFFE, STUART; VAN RADERS, PETRONELLA; More

Retina. 29(3):387-394, March 2009.

CAUSES OF MACULAR SEROUS RETINAL DETACHMENTS IN JAPANESE PATIENTS 40 YEARS AND OLDER

HIKICHI, TAIICHI; OHTSUKA, HIDEO; HIGUCHI, MAKOTO; More

Retina. 29(3):395-404, March 2009.





Show: